Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
Axel Grothey(Mayo Clinic in Arizona), Eric Van Cutsem(KU Leuven), Alberto Sobrero(Ospedale Policlinico San Martino), Salvatore Siena(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Alfredo Falcone(Azienda Ospedaliera Universitaria Pisana), Marc Ychou(CEA Valduc), Yves Humblet(UCLouvain Saint-Louis Brussels), Olivier Bouché(Centre Hospitalier Universitaire de Reims), Laurent Mineur(Institut Sainte Catherine), Carlo Barone(Università Cattolica del Sacro Cuore), Antoine Adenis(Centre Oscar Lambret), Josep Tabernero(Universitat Autònoma de Barcelona), Takayuki Yoshino(National Cancer Center Hospital East), Heinz‐Josef Lenz(University of Southern California), Richard M. Goldberg(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Daniel J. Sargent(Mayo Clinic in Arizona), Frank Cihon(Bayer (United States)), Lisa Cupit(Bayer (United States)), Andrea Wagner(Bayer (Germany)), Dirk Laurent(Bayer (Germany))
Cited by 2,883
Abstract
Related Papers
No related papers found
Powered by citation graph analysis